Asunto(s)
Insuficiencia Suprarrenal/complicaciones , Insuficiencia Suprarrenal/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Hidrocortisona/uso terapéutico , Choque Cardiogénico/tratamiento farmacológico , Choque Cardiogénico/etiología , Agonistas alfa-Adrenérgicos/uso terapéutico , Adulto , Antihipertensivos/uso terapéutico , Aspirina/uso terapéutico , Bisoprolol/uso terapéutico , Enfermedad Crítica , Epinefrina/uso terapéutico , Fibrinolíticos/uso terapéutico , Hirudinas , Humanos , Masculino , Fragmentos de Péptidos/uso terapéutico , Piperazinas/uso terapéutico , Clorhidrato de Prasugrel , Ramipril/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Tiofenos/uso terapéutico , Resultado del TratamientoRESUMEN
INTRODUCTION: Solitary fibromas are rare anatomo-pathological entities, described initially in the pleural cavity. The mesenchymal origin of these tumours explains their widespread distribution. CASE REPORT: The authors report a case of solitary fibroma of the trachea in a woman of 30 years of age, presenting as acute respiratory distress and preceded by a 2 year history of episodes of dyspnoea diagnosed as unstable asthma. CT and MRI imaging showed evidence of a localised tracheal tumour without mediastinal infiltration. The images and macroscopic appearances were non-specific. Bronchoscopic resection of the tumour gave immediate relief of the symptoms. Histology, which was positive for anti-CD34 antibodies and negative for epithelial, muscular and neurological markers, led to a diagnosis of solitary fibroma with no evidence of malignancy. CONCLUSION: To our knowledge, this observation is the first description of a primary solitary fibroma localised to the trachea. The clinical and radiological features are no different from those of other tracheal tumours. After excision, the prognosis is good but long-term follow-up is necessary on account of the risk of local recurrence or metastasis.